ALEXANDRIA PHARMACEUTICALS financial statements, including revenue, expenses, profit, and loss

The total revenue of AXPH for the last quarter is 511.95 M EGP, and it's 4.94% higher compared to the previous quarter. The net income of Q2 24 is 78.64 M EGP.